NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/09/2024
Back to search
Official data from USPTO
PATIENT FOCUSED MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PATIENT FOCUSED MEDICINE
ST13
US500000085763460Class
5
Filing
85763460
Registration
4313188
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
03/09/2024
Trademark type
Word
Nice classes
5
Filing date
10/25/2012
Registration date
04/02/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/09/2024
Last transaction
03/09/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
08/01/2010
First use in commerce
08/01/2010
Drawing code
4
Owner type
03
Owner location
Sarasota, FL, US
Examiner
SINGH, TEJBIR
Law office
L60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Asepsis Pharmaceuticals Inc.
Asepsis Pharmaceuticals Inc.
Representatives
Jeffrey S. Bernard Suiter Swantz pc llo
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydrationnutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systemfor the treatment of inflammatory disordersfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Potassium preparations for pharmaceutical purposes
Publications
History of USPTO decisions and trademark events.
27 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/09/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/09/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
09/26/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/02/2022
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
05/09/2018
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
05/09/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/09/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/05/2018
ES8R
TEAS SECTION 8 RECEIVED
05/05/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/30/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/02/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/15/2013
PUBO
PUBLISHED FOR OPPOSITION
01/15/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/26/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/13/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/06/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
12/06/2012
ALIE
ASSIGNED TO LIE
12/05/2012
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/05/2012
GNEA
EXAMINERS AMENDMENT E-MAILED
12/05/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/05/2012
DOCK
ASSIGNED TO EXAMINER
12/05/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/31/2012
NWAP
NEW APPLICATION ENTERED
10/29/2012
Continuous trademark protection
Get notified about every new filing that threatens PATIENT FOCUSED MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.